Drug costs "This so-called investigation has ignored the real affordability problems people face, like rising deductibles and other out-of-pocket costs," said a PhRMA representative. (Photo: Shutterstock)

House Democrats accuse drug manufacturers of unfairly raising prices and gaming the system to delay generic competition in a way that is "unsustainable, unjustified and unfair to patients and taxpayers."

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.